Common Contracts
2 similar Thirteenth Supplemental Indenture contracts by Valeant Pharmaceuticals International, Inc.
THIRTEENTH SUPPLEMENTAL INDENTUREThirteenth Supplemental Indenture • November 1st, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
THIRTEENTH SUPPLEMENTAL INDENTURE, dated as of October 23, 2013 (the “Thirteenth Supplemental Indenture”), by and among Akcinė bendrovė SANITAS (Public limited liability company SANITAS), a company continued under the laws of the Republic of Lithuania (“Sanitas”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).
THIRTEENTH SUPPLEMENTAL INDENTUREThirteenth Supplemental Indenture • November 1st, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
THIRTEENTH SUPPLEMENTAL INDENTURE, dated as of October 23, 2013 (the “Thirteenth Supplemental Indenture”), by and among Akcinė bendrovė SANITAS (Public limited liability company SANITAS), a company continued under the laws of the Republic of Lithuania (“Sanitas”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).
